• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Core Laboratories Inc.

    3/31/25 4:59:20 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy
    Get the next $CLB alert in real time by email
    DEFA14A 1 clb_-_defa_14a_2025.htm DEFA14A DEFA14A

     

    UNITED STATES

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a) of the Securities

    Exchange Act of 1934 (Amendment No. )

     

    Filed by the Registrant ☑

    Filed by a Party other than the Registrant ☐

     

    Check the appropriate box:

    ☐ Preliminary Proxy Statement

    ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐ Definitive Proxy Statement

    ☑ Definitive Additional Materials

    ☐ Soliciting Material Pursuant to §240.14a-12

     

    Core Laboratories Inc.

     

    (Name of Registrant as Specified In Its Charter)

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):

    ☑ No fee required

    ☐ Fee paid previously with preliminary materials

    ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     

    1


     

    *** Exercise Your Right to Vote ***

    IMPORTANT NOTICE Regarding the Availability of Proxy Materials

    for the Shareholder Meeting To Be Held on May 21, 2025

     

     

     

     

     

    Meeting Information

    CORE LABORATORIES INC.

     

    Meeting Type:

    Annual Meeting

     

     

    For holders as of:

    March 26, 2025

     

     

    Date: May 21, 2025

    Time: 9:00 am CDT

     

     

    Location:

    The Hotel Zaza, Memorial City

     

     

     

    9787 Katy Freeway

     

     

     

    Houston, Texas 77024

    img30012973_0.jpg

    CORE LABORATORIES INC.

     

    You are receiving this communication because you hold shares in the above named company.

    6316 WINDFERN ROAD

    HOUSTON, TX 77040

     

    This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting.

     

     

     

     

     

    The proxy materials are available at www.proxyvote.com. If you want to receive a paper or e-mail copy of these documents, you must request one. There is no charge to you for requesting a copy. Please make your request for a copy (as instructed on the reverse side) on or before May 7, 2025 to facilitate timely delivery.

     

     

     

     

     

    See the reverse side of this notice to obtain proxy materials and voting instructions.

     

     

    2


     

    — Before You Vote —

    How to Access the Proxy Materials

     

    Proxy Materials Available to VIEW or RECEIVE:

    NOTICE AND PROXY STATEMENT

    ANNUAL REPORT

     

     

     

     

     

     

     

    How to View Online:

     

     

     

     

    Have the information that is printed in the box marked by the arrow 

    XXXX XXXX XXXX

    (located on the following page) and

    visit: www.proxyvote.com.

     

     

     

     

     

    How to Request and Receive a PAPER or E-MAIL Copy:

    If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

     

    1) BY INTERNET:

    The proxy materials are available at www.proxyvote.com.

     

    2) BY TELEPHONE:

    1-800-579-1639

     

     

     

    3) BY E-MAIL*:

    [email protected]

     

     

     

     

     

     

     

    * If requesting materials by e-mail, please send a blank e-mail with the information that is printed

    in the box marked by the arrow 

    XXXX XXXX XXXX

     (located on the following page) in the subject line.

     

     

     

     

     

    Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 7, 2025 to facilitate timely delivery.

     

     

    — How To Vote —

    Please Choose One of the Following Voting Methods

    Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

     

     

     

    Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box

    marked by the arrow 

    XXXX XXXX XXXX

    available and follow the instructions.

     

     

     

    Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

     

     

     

     

    3


     

    The Board of Directors recommends you vote FOR the following:

     

    For

    Withhold

    1.

    To elect one new Class II Director and re-elect two current Class II Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2028 and until their successors shall have been duly elected and qualified;

     

     

     

     

    1a) Martha Z. Carnes

    

    

     

     

    1b) Katherine Murray

    

    

     

     

    1c) Rob Martinovich

    

    

    The Board of Directors recommends you vote FOR the following proposals:

    For

    Against

    Abstain

     

     

     

     

     

     

     

    2.

    To ratify the appointment of KPMG LLP as the Company’s independent registered public accountants for the year ending December 31, 2025;

    

    

    

     

    3.

    To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis (“CD&A”), and the compensation of the Company’s named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commission’s compensation disclosure rules, including the compensation tables.

    

    

    

     

     

     

     

     

     

    NOTE: Such other business as may properly come before the annual meeting or any adjournment thereof shall be voted in accordance with the discretion of the attorneys and proxies appointed hereby.

     

     

     

     

    4


    Get the next $CLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLB

    DatePrice TargetRatingAnalyst
    3/12/2025$15.00 → $16.00Sell → Neutral
    Citigroup
    6/30/2023$22.00 → $21.00Neutral → Sell
    Citigroup
    4/18/2023$21.50Neutral → Underperform
    BofA Securities
    1/9/2023Underperform → Neutral
    BofA Securities
    10/7/2022$24.00 → $17.00Sell → Neutral
    Citigroup
    9/26/2022$20.00Equal-Weight → Underweight
    Morgan Stanley
    4/18/2022$19.50 → $21.30Neutral → Underweight
    Piper Sandler
    1/18/2022$32.00 → $30.00Equal-Weight
    Morgan Stanley
    More analyst ratings